Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
29 March 2019 | Story Lacea Loader

No deregistration of students at the University of the Free State (UFS) will be effected until after the Financial Appeals Committee has concluded its process on 5 April 2019.

During a meeting between the university management and the Institutional Student Representative Council (ISRC) today, the following agreement was reached:

  1. The date for the submission of appeals has been extended to Tuesday 2 April 2019 at 12:00. No further extension will be given. The application form for the Financial Appeals Committee has previously been sent to the ufs4life email addresses of all provisionally registered students.
  2. Students who have appealed their National Student Financial Aid Scheme (NSFAS) outcomes will not be deregistered while awaiting the result of the outcome of their appeal.
  3. Verified final-year students who are provisionally registered will not be deregistered. This will be subject to verification by the Financial Appeals Committee. These students must also submit an appeal.
  4. All other categories of students must submit their appeals to the Financial Appeals Committee.

NB: The documentation mentioned above must be submitted to the Student Finance Office as indicated on the financial appeals form sent to students via their ufs4life email address.

The UFS has taken a pro-poor approach to assist students who are academically deserving. With this approach, the university’s fee structure is much less than that of many public institutions of higher learning in the country. Senior students are also supported through a provisional registration process that grants them the opportunity to pay a reduced amount in order to register, enabling them to fully participate in all activities while extension is provided to secure the necessary funding for their studies.

The university has made a number of concessions to ensure that students are not financially excluded during the 2019 academic year. Many of these concessions were raised by the ISRC on behalf of students and was agreed upon by the university management.  

These concessions include:

  1. Students who have confirmed NSFAS funding for 2019 with historic debt, are to secure registration. This has taken place before the announcement on 24 March 2019 by the Minister of Higher Education and Training, Naledi Pandor, that the historic debt of NSFAS students will be settled by the department.

     

  2. Students in the missing middle who received a gap grant in 2018, have been assisted to pay a lesser amount to register fully for 2019.

     

  3. Students with historic debt who are not receiving the gap grant have also been assisted to register for 2019. Acceptable payment plans for these students have been agreed upon with the university’s Student Finance Office.

     

  4. First-time entering students were assisted with a reduced first payment to enable them to register for 2019.

     

  5. Final-year students with historic debt of less than R20 000 who could not have been assisted in any of the above concessions explained above were allowed to register.

     

  6. Students who are provisionally registered and who could not find the necessary financial means, had the opportunity to submit appeals to the Financial Appeals Committee by 29 March 2019 to secure their registration. This committee comprises representatives of the university management, as well as members of the ISRC. This committee is scheduled to meet on 5 April 2019.

The above is evidence of the multi-layered efforts by the university to support academic deserving students as far as it is practically possible in order to avoid financial exclusion. Additionally, the university’s Student Finance Office has since the beginning of the academic year communicated extensively on the process with students who are at risk of being deregistered.  

Historically, less than 0,5% of registered students at the UFS are not able to find the necessary means to secure their registration.

To support students in their academic efforts, all matters pertaining to registration should be concluded by the end of the first term. A cut-off date is set by which all registration processes – including concessions – are to be concluded. This date – 31 March 2019 – has already been set in 2018, which is the result of consultation with all relevant stakeholders, including the IRSC.

This cut-off date has now been extended to Tuesday 2 April 2019 at 12:00.

Released by:

Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept